Topics

Axial Biotherapeutics Presents New Preclinical Data from AB-2004 Program Demonstrating Reduction of Microbiome-Derived Metabolites in Mouse Models with Autism Spectrum Disorder at the International Society for Autism Research (INSAR) 2019 Annual Meeting

11:00 EDT 2 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
- Preclinical results support development of AB-2004 as potential treatment for gastrointestinal dysfunction and associated behavioral symptoms of Autism Spectrum Disorder – - Patient screening for Phase 1b/2a clinica...

Other Sources for this Article

Investor:
Julie Seidel
Stern Investor Relations
(212) 362-1200
Julie.Seidel@sternir.com

NEXT ARTICLE

More From BioPortfolio on "Axial Biotherapeutics Presents New Preclinical Data from AB-2004 Program Demonstrating Reduction of Microbiome-Derived Metabolites in Mouse Models with Autism Spectrum Disorder at the International Society for Autism Research (INSAR) 2019 Annual Meeting"

Quick Search

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...